Literature DB >> 12403303

Synthesis and some pharmacological properties of 3-(4-phenyl-5-oxo-1,2,4-triazolin-1-ylmethyl)-1,2,4-triazolin-5-thione derivatives.

Maria Dobosz1, Marta Struga, Anna Chodkowska, Ewa Jagiełło-Wójtowicz, Krystyna Stepniak, Anna E Kozioł.   

Abstract

In the reaction of (4-phenyl- or 3,4-diphenyl-5-oxo-1,2,4-triazeolin-1-ylmethyl)-carbohydrazide (IIa, IIb) with isothiocyanates the thiosemicarbazide derivatives [IIIa, b - IXa, b] were obtained. Cyclization of those compounds in the presence of 2% or 10% NaOH led to formation of derivatives with the 1,2,4-triazolin-5-thione system [Xa, b - XV[a, b]. Molecular structure proposed for this group of compounds was confirmed by X-ray structure analysis of Xa and XIVa. Compounds Xa, XIIa and XIVa were investigated pharmacologically for their central properties in mice. It was shown that only compound XIIa produced antinociceptive effects in mice.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12403303

Source DB:  PubMed          Journal:  Acta Pol Pharm        ISSN: 0001-6837            Impact factor:   0.330


  3 in total

1.  4-Ethyl-3-(2-thienylmeth-yl)-Δ-1,2,4-triazoline-5-thione.

Authors:  Monika Wujec; Liliana Mazur; Zofia Rzączyńska
Journal:  Acta Crystallogr Sect E Struct Rep Online       Date:  2009-01-10

2.  Synthesis and Biological Activities of Ethyl 2-(2-pyridylacetate) Derivatives Containing Thiourea, 1,2,4-triazole, Thiadiazole and Oxadiazole Moieties.

Authors:  Daniel Szulczyk; Piotr Tomaszewski; Michał Jóźwiak; Anna E Kozioł; Tadeusz Lis; David Collu; Filippo Iuliano; Marta Struga
Journal:  Molecules       Date:  2017-03-06       Impact factor: 4.411

3.  Synthesis, Structural Studies and Biological Evaluation of Connections of Thiosemicarbazide, 1,2,4-Triazole and 1,3,4-Thiadiazole with Palmitic Acid.

Authors:  Michał Jóźwiak; Karolina Stępień; Małgorzata Wrzosek; Wioletta Olejarz; Grażyna Kubiak-Tomaszewska; Anna Filipowska; Wojciech Filipowski; Marta Struga
Journal:  Molecules       Date:  2018-04-03       Impact factor: 4.411

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.